Clinical Trial Update: A Randomized Clinical Trial of Adipose-derived Stem Cells in Treatment of Non Revascularizable Ischemic Myocardium [Phase 1]

View source ↗

Summary

Phase 1 randomized trial evaluating adipose-derived stem cells for non-revascularizable ischemic myocardium has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiovascular Disease
• Coronary Arteriosclerosis
• Coronary Artery Disease
• Coronary Disease
• Ischemic Heart Disease

Drugs mentioned

• Adipose-Derived Stem Cells (adipose-derived stem cells)

Snippet

Sponsor: Cytori Therapeutics | Conditions: Ischemic Heart Disease, Coronary Arteriosclerosis | Phase 1 | Status: COMPLETED